EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 376 filers reported holding EXELIXIS INC in Q2 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,718,511 | +11.3% | 124,417 | -2.7% | 0.12% | +12.6% |
Q2 2023 | $2,442,774 | -11.0% | 127,827 | -9.6% | 0.10% | -12.7% |
Q1 2023 | $2,744,244 | -71.6% | 141,383 | -76.5% | 0.12% | -73.2% |
Q4 2022 | $9,669,602 | +9.9% | 602,843 | +7.4% | 0.44% | -0.5% |
Q3 2022 | $8,798,000 | -24.9% | 561,121 | -0.3% | 0.44% | -15.1% |
Q2 2022 | $11,722,000 | -12.0% | 562,993 | -4.1% | 0.52% | +4.2% |
Q1 2022 | $13,313,000 | +30.3% | 587,264 | +5.0% | 0.50% | +42.7% |
Q4 2021 | $10,221,000 | -21.7% | 559,121 | -9.4% | 0.35% | -21.5% |
Q3 2021 | $13,050,000 | +15.5% | 617,306 | -0.5% | 0.45% | +23.1% |
Q2 2021 | $11,301,000 | -0.9% | 620,245 | +22.9% | 0.36% | -8.6% |
Q1 2021 | $11,404,000 | +27.6% | 504,812 | +13.3% | 0.40% | +13.8% |
Q4 2020 | $8,938,000 | +11.3% | 445,362 | +35.6% | 0.35% | -4.6% |
Q3 2020 | $8,032,000 | +257.5% | 328,500 | +247.1% | 0.37% | +255.3% |
Q2 2020 | $2,247,000 | +35.7% | 94,636 | -1.6% | 0.10% | +24.1% |
Q1 2020 | $1,656,000 | – | 96,169 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |